Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Cardiac sarcoidosis (CS) is a rare inflammatory disorder characterised by the presence of
non-caseating granulomas within the myocardium. Contemporary studies have revealed …

Aims Cardiac sarcoidosis (CS) is a potentially fatal condition that varies in its clinical
presentation. Here, we describe baseline characteristics at presentation along with …

Cardiac sarcoidosis can mimic any cardiomyopathy in different stages. Noncaseating
granulomatous inflammation can be missed, because of the nonhomogeneous distribution …

Objective Owing to the paucity of data, this study aimed to investigate sex differences in
clinical features and prognosis of patients with cardiac sarcoidosis (CS). Methods This study …

Aim Data on the clinical features and prognosis of patients with isolated cardiac sarcoidosis
(iCS) are limited. This study evaluated the clinical characteristics and prognostic impact of …

Aims Identifying patients with cardiac sarcoidosis (CS) who are at an increased risk of
sudden cardiac death (SCD) poses a clinical challenge. We sought to identify the optimal …

One of the goals in the work-up of sarcoidosis is to assess the extent and severity of organ
involvement. Timely and accurate assessment leads to determination of treatment indication …

Cardiac sarcoidosis (CS), an increasingly recognized disease of unknown etiology, is
associated with significant morbidity and mortality. Given the limited diagnostic yield of …

Sarcoidosis is a multisystem disorder of unknown etiology. The leading hypothesis involves
an antigen-triggered dysregulated T-cell-driven immunologic response leading to non …